Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Novostia logo — Heart valves for life, for patients of any age, including ch...

Novostia

Heart valves for life, for patients of any age, including children

Founded 2017 Switzerland Switzerland 15 employees Total: $20.23M Health Care, Medical Devices

General Information

Company Name Novostia
Founded Year 2017
Location Switzerland Switzerland
Employees 15
Industries Health Care, Medical Devices
Business Model B2B, B2D
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Novostia. To contact Novostia, visit novostia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Novostia compare?

A PDF of Novostia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Novostia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Novostia

Novostia, headquartered in Switzerland, is a promising medical device startup founded in 2017. The company specializes in developing innovative artificial heart valves suitable for patients of any age, including children. With its slogan, "Heart valves for life, for patients of any age, including children," Novostia focuses on transforming treatment for aortic and mitral valve disease.

As the health care industry continues to seek novel solutions for complex cardiovascular issues, Novostia's commitment to advancing their technology to clinical trials and regulatory approvals positions them as a key player in this space. The potential to improve the quality of life for millions of patients worldwide offers a compelling value proposition for investors.

In its latest funding round on 01 May 2023, the company secured a €2.50M Series A investment. This financial backing underscores confidence in Novostia's innovative approach and their trajectory in the Health Care and Medical Devices industries.

Business keywords: medical device company, heart valve technology, innovative healthcare, aortic valve disease, mitral valve disease, clinical trials, regulatory approvals, quality of life improvement, cardiovascular health, pediatric cardiology, lifesaving technology

Services & Products

Development of artificial heart valves
Research and innovation in cardiovascular solutions

Target Customers

Patients requiring heart valve replacement Young patients including children Healthcare providers specializing in cardiology Cardiovascular surgeons

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC €5.96M -
01 Sep 2024
Series A €2.50M -
01 May 2023
Grant $2.78M -
01 Jan 2020
Grant €2.49M 1
European Innovation Council
European Innovation Council
01 Oct 2019
Seed Fr.6.50M -
01 Feb 2019

Novostia Alternatives & Competitors

View All Alternatives
Novostia vs
Arbor Surgical Technologies
Arbor Surgical Technologies

Developing innovative heart valve solutions to advance patient care and enhance surgical efficiency.

Series C
Health Care, Manufacturing
Novostia vs
AMT Medical
AMT Medical The Netherlands

The future of bypass surgery

Grant
42 employees
Health Care, Medical Devices
Novostia vs
HighLife
HighLife France

Trans-septal Mitral Valve Replacement

Series C
84 employees
Health Care, Medical Devices
Also compare with: Novostia vs Pi-Cardia Pi-Cardia View all alternatives

FAQ About Novostia

Heart valves for life, for patients of any age, including children
Novostia was founded in 2017.
Novostia is headquartered in Switzerland.
Novostia operates in Health Care and Medical Devices. Its work centres on medical device company, heart valve technology, innovative healthcare and aortic valve disease. Its customers include Patients requiring heart valve replacement, Young patients including children and Healthcare providers specializing in cardiology.
Novostia has a B2B and B2D business model. Its revenue comes from Product Sales and Licensing.
Novostia has approximately 15 employees.
Novostia has completed 5 funding rounds, raising a total of $20.23M.
Novostia offers: Development of artificial heart valves, Research and innovation in cardiovascular solutions.
Top alternatives and competitors to Novostia include Arbor Surgical Technologies, AMT Medical, HighLife, Cardiac Dimensions, Annoviant. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novostia and Arbor Surgical Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Novostia, https://bouncewatch.com/company/novostia, updated 28 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes